Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 700 | 140 | 410 | 880 | 420 |
| Depreciation Amortization | 640 | 270 | 250 | 230 | 170 |
| Other Working Capital | -730 | 920 | 420 | 190 | 50 |
| Other Operating Activity | 150 | 20 | 320 | 590 | 260 |
| Operating Cash Flow | $760 | $1,350 | $1,400 | $1,890 | $900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -170 | -330 | -300 | -240 | -870 |
| Other Investing Activity | -1,200 | -2,830 | -100 | -790 | -90 |
| Investing Cash Flow | $-1,370 | $-3,160 | $-400 | $-1,030 | $-960 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 110 | 140 | 2 | -390 | 40 |
| Financing Cash Flow | $110 | $140 | $2 | $-390 | $40 |
| Beginning Cash Position | 1,700 | 3,350 | 2,350 | 1,880 | 1,890 |
| End Cash Position | 1,200 | 1,700 | 3,350 | 2,350 | 1,880 |
| Net Cash Flow | $-500 | $-1,650 | $1,000 | $470 | $-10 |
| Free Cash Flow | |||||
| Operating Cash Flow | 760 | 1,350 | 1,400 | 1,890 | 900 |
| Free Cash Flow | 760 | 1,350 | 1,400 | 1,890 | 900 |